---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-031604"
form_type: "8-K"
ticker: "TRAK"
cik: "0000050471"
company_name: "ReposiTrak, Inc."
filed_at: "2026-09-30T20:19:46+00:00"
generated_at: "2026-10-12T14:06:11.317666+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ReposiTrak FY2026 net income rises 8% to $7.6M; Q4 EPS up to $0.11 as cash hits $27.3M

## Summary
- FY2026 revenue rose 3% to $23.3M; operating income up 26% to $7.8M as operating expense fell 6% to $15.4M.
- Q4 revenue was $5.6M, down 3% YoY; Q4 GAAP net income rose 16% to $2.1M and diluted EPS was $0.11 vs $0.09.
- FY2026 GAAP net income was $7.6M (+8%); net income to common shareholders $7.4M (+12%); diluted EPS $0.39 vs $0.35.
- Returned $5.3M to shareholders in FY2026: redeemed 175,233 preferred shares at $10.70 (~$1.9M) and bought back 143,904 common shares at avg $12.50 ($1.8M); dividend $0.02/qtr.
- In SPAR Group collaboration, ReposiTrak agreed to provide a $4.0M credit facility and acquired ~$2.4M of SPAR common stock; expects traceability demand to accelerate.

## SEC filing metadata
- accession: 0001437749-26-031604
- form_type: 8-K
- ticker: TRAK
- cik: 0000050471
- company_name: ReposiTrak, Inc.
- filed_at: 2026-09-30T20:19:46+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/50471/000143774926031604/0001437749-26-031604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/50471/000143774926031604/trak20260930_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-031604
- JSON: https://secwatch.observer/filing/0001437749-26-031604.json
- Plain text: https://secwatch.observer/filing/0001437749-26-031604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
